Afuco™ Anti-Human GAP43 ADCC Therapeutic Antibody, ADCC Enhanced

Anti-GAP43 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies to the growth-associated protein, GAP-43, introduced intracellularly using a lipid carrier, blocked the differentiation induced by dbcAMP. Antibodies to GAP43, at a low concentration, blocked neurite out-growth induced by serum withdrawal when cells were grown on a relatively unadhesive substrate.
Supplier Creative Biolabs
Product # AFC-286CL
Pricing Inquiry
Host Chimeric human/mouse
Target GAP43
Species Reactivity Mouse
Type ADCC enhanced antibody
Storage ≤1 year at -20°C.
Feedback